De la Torre, A. and Ramírez Ibarguen, A.-F. (2024) “Minimal Residual Disease in Myeloma in 2024: Where We are Today”, Canadian Hematology Today. Toronto, Canada, 3(3), pp. 47–54. doi: 10.58931/cht.2024.3360.